2024 ICD-10-PCS Tables |
Back to ICD-10 PCS (Procedure) Home |
The ICD-10-PCS Tables contains all valid codes in table format. The tables are arranged in alphanumeric order, and organized into separate tables according to the first three characters of the seven-character code.
After the first three characters are selected, you will see more lists of combinations of the remaining characters that comprise valid PCS codes. Each such list of combinations is displayed have a title which corresponds to the column headings ("Body Part", "Approach", "Device" and "Qualifier" for section zero).
| Section | 3 | Administration |
| Body System | E | Physiological Systems and Anatomical Regions |
| Operation | 0 | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| Body System / Region | Approach | Substance | Qualifier |
|---|---|---|---|
| 0: Skin and Mucous Membranes |
X: External |
0: Antineoplastic |
5: Other Antineoplastic M: Monoclonal Antibody |
| 0: Skin and Mucous Membranes |
X: External |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 0: Skin and Mucous Membranes |
X: External |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine B: Anesthetic Agent K: Other Diagnostic Substance M: Pigment N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| 0: Skin and Mucous Membranes |
X: External |
G: Other Therapeutic Substance |
C: Other Substance |
| 1: Subcutaneous Tissue |
0: Open |
2: Anti-infective |
A: Anti-Infective Envelope |
| 1: Subcutaneous Tissue |
3: Percutaneous |
0: Antineoplastic |
5: Other Antineoplastic M: Monoclonal Antibody |
| 1: Subcutaneous Tissue |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective A: Anti-Infective Envelope |
| 1: Subcutaneous Tissue |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| 1: Subcutaneous Tissue |
3: Percutaneous |
4: Serum, Toxoid and Vaccine |
0: Influenza Vaccine Z: No Qualifier |
| 1: Subcutaneous Tissue |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| 1: Subcutaneous Tissue |
3: Percutaneous |
V: Hormone |
G: Insulin J: Other Hormone |
| 2: Muscle |
3: Percutaneous |
0: Antineoplastic |
5: Other Antineoplastic M: Monoclonal Antibody |
| 2: Muscle |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 2: Muscle |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| 2: Muscle |
3: Percutaneous |
4: Serum, Toxoid and Vaccine |
0: Influenza Vaccine Z: No Qualifier |
| 2: Muscle |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| 3: Peripheral Vein |
0: Open |
0: Antineoplastic |
2: High-dose Interleukin-2 3: Low-dose Interleukin-2 5: Other Antineoplastic M: Monoclonal Antibody P: Clofarabine |
| 3: Peripheral Vein |
0: Open |
1: Thrombolytic |
6: Recombinant Human-activated Protein C 7: Other Thrombolytic |
| 3: Peripheral Vein |
0: Open |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 3: Peripheral Vein |
0: Open |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine 6: Nutritional Substance 7: Electrolytic and Water Balance Substance F: Intracirculatory Anesthetic H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives P: Platelet Inhibitor R: Antiarrhythmic T: Destructive Agent X: Vasopressor |
Z: No Qualifier |
| 3: Peripheral Vein |
0: Open |
G: Other Therapeutic Substance |
C: Other Substance N: Blood Brain Barrier Disruption |
| 3: Peripheral Vein |
0: Open |
U: Pancreatic Islet Cells |
0: Autologous 1: Nonautologous |
| 3: Peripheral Vein |
0: Open |
V: Hormone |
G: Insulin H: Human B-type Natriuretic Peptide J: Other Hormone |
| 3: Peripheral Vein |
0: Open |
W: Immunotherapeutic |
K: Immunostimulator L: Immunosuppressive |
| 3: Peripheral Vein |
3: Percutaneous |
0: Antineoplastic |
2: High-dose Interleukin-2 3: Low-dose Interleukin-2 5: Other Antineoplastic M: Monoclonal Antibody P: Clofarabine |
| 3: Peripheral Vein |
3: Percutaneous |
1: Thrombolytic |
6: Recombinant Human-activated Protein C 7: Other Thrombolytic |
| 3: Peripheral Vein |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 3: Peripheral Vein |
3: Percutaneous |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine 6: Nutritional Substance 7: Electrolytic and Water Balance Substance F: Intracirculatory Anesthetic H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives P: Platelet Inhibitor R: Antiarrhythmic T: Destructive Agent X: Vasopressor |
Z: No Qualifier |
| 3: Peripheral Vein |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance N: Blood Brain Barrier Disruption Q: Glucarpidase R: Other Therapeutic Monoclonal Antibody |
| 3: Peripheral Vein |
3: Percutaneous |
U: Pancreatic Islet Cells |
0: Autologous 1: Nonautologous |
| 3: Peripheral Vein |
3: Percutaneous |
V: Hormone |
G: Insulin H: Human B-type Natriuretic Peptide J: Other Hormone |
| 3: Peripheral Vein |
3: Percutaneous |
W: Immunotherapeutic |
K: Immunostimulator L: Immunosuppressive |
| 4: Central Vein |
0: Open |
0: Antineoplastic |
2: High-dose Interleukin-2 3: Low-dose Interleukin-2 5: Other Antineoplastic M: Monoclonal Antibody P: Clofarabine |
| 4: Central Vein |
0: Open |
1: Thrombolytic |
6: Recombinant Human-activated Protein C 7: Other Thrombolytic |
| 4: Central Vein |
0: Open |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 4: Central Vein |
0: Open |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine 6: Nutritional Substance 7: Electrolytic and Water Balance Substance F: Intracirculatory Anesthetic H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives P: Platelet Inhibitor R: Antiarrhythmic T: Destructive Agent X: Vasopressor |
Z: No Qualifier |
| 4: Central Vein |
0: Open |
G: Other Therapeutic Substance |
C: Other Substance N: Blood Brain Barrier Disruption |
| 4: Central Vein |
0: Open |
V: Hormone |
G: Insulin H: Human B-type Natriuretic Peptide J: Other Hormone |
| 4: Central Vein |
0: Open |
W: Immunotherapeutic |
K: Immunostimulator L: Immunosuppressive |
| 4: Central Vein |
3: Percutaneous |
0: Antineoplastic |
2: High-dose Interleukin-2 3: Low-dose Interleukin-2 5: Other Antineoplastic M: Monoclonal Antibody P: Clofarabine |
| 4: Central Vein |
3: Percutaneous |
1: Thrombolytic |
6: Recombinant Human-activated Protein C 7: Other Thrombolytic |
| 4: Central Vein |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 4: Central Vein |
3: Percutaneous |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine 6: Nutritional Substance 7: Electrolytic and Water Balance Substance F: Intracirculatory Anesthetic H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives P: Platelet Inhibitor R: Antiarrhythmic T: Destructive Agent X: Vasopressor |
Z: No Qualifier |
| 4: Central Vein |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance N: Blood Brain Barrier Disruption Q: Glucarpidase R: Other Therapeutic Monoclonal Antibody |
| 4: Central Vein |
3: Percutaneous |
V: Hormone |
G: Insulin H: Human B-type Natriuretic Peptide J: Other Hormone |
| 4: Central Vein |
3: Percutaneous |
W: Immunotherapeutic |
K: Immunostimulator L: Immunosuppressive |
| 5: Peripheral Artery 6: Central Artery |
0: Open 3: Percutaneous |
0: Antineoplastic |
2: High-dose Interleukin-2 3: Low-dose Interleukin-2 5: Other Antineoplastic M: Monoclonal Antibody P: Clofarabine |
| 5: Peripheral Artery 6: Central Artery |
0: Open 3: Percutaneous |
1: Thrombolytic |
6: Recombinant Human-activated Protein C 7: Other Thrombolytic |
| 5: Peripheral Artery 6: Central Artery |
0: Open 3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 5: Peripheral Artery 6: Central Artery |
0: Open 3: Percutaneous |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine 6: Nutritional Substance 7: Electrolytic and Water Balance Substance F: Intracirculatory Anesthetic H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives P: Platelet Inhibitor R: Antiarrhythmic T: Destructive Agent X: Vasopressor |
Z: No Qualifier |
| 5: Peripheral Artery 6: Central Artery |
0: Open 3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance N: Blood Brain Barrier Disruption |
| 5: Peripheral Artery 6: Central Artery |
0: Open 3: Percutaneous |
V: Hormone |
G: Insulin H: Human B-type Natriuretic Peptide J: Other Hormone |
| 5: Peripheral Artery 6: Central Artery |
0: Open 3: Percutaneous |
W: Immunotherapeutic |
K: Immunostimulator L: Immunosuppressive |
| 7: Coronary Artery 8: Heart |
0: Open 3: Percutaneous |
1: Thrombolytic |
6: Recombinant Human-activated Protein C 7: Other Thrombolytic |
| 7: Coronary Artery 8: Heart |
0: Open 3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| 7: Coronary Artery 8: Heart |
0: Open 3: Percutaneous |
K: Other Diagnostic Substance P: Platelet Inhibitor |
Z: No Qualifier |
| 7: Coronary Artery 8: Heart |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| 9: Nose |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
0: Antineoplastic |
5: Other Antineoplastic M: Monoclonal Antibody |
| 9: Nose |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| 9: Nose |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| 9: Nose |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
G: Other Therapeutic Substance |
C: Other Substance |
| A: Bone Marrow |
3: Percutaneous |
0: Antineoplastic |
5: Other Antineoplastic M: Monoclonal Antibody |
| A: Bone Marrow |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| B: Ear |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| B: Ear |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| B: Ear |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
3: Anti-inflammatory B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| B: Ear |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
G: Other Therapeutic Substance |
C: Other Substance |
| C: Eye |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| C: Eye |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| C: Eye |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
3: Anti-inflammatory B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance M: Pigment N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| C: Eye |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
G: Other Therapeutic Substance |
C: Other Substance |
| C: Eye |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
S: Gas |
F: Other Gas |
| D: Mouth and Pharynx |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| D: Mouth and Pharynx |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| D: Mouth and Pharynx |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
3: Anti-inflammatory 4: Serum, Toxoid and Vaccine 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives R: Antiarrhythmic T: Destructive Agent |
Z: No Qualifier |
| D: Mouth and Pharynx |
3: Percutaneous 7: Via Natural or Artificial Opening X: External |
G: Other Therapeutic Substance |
C: Other Substance |
| E: Products of Conception G: Upper GI H: Lower GI K: Genitourinary Tract N: Male Reproductive |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| E: Products of Conception G: Upper GI H: Lower GI K: Genitourinary Tract N: Male Reproductive |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| E: Products of Conception G: Upper GI H: Lower GI K: Genitourinary Tract N: Male Reproductive |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| E: Products of Conception G: Upper GI H: Lower GI K: Genitourinary Tract N: Male Reproductive |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| E: Products of Conception G: Upper GI H: Lower GI K: Genitourinary Tract N: Male Reproductive |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
S: Gas |
F: Other Gas |
| E: Products of Conception G: Upper GI H: Lower GI K: Genitourinary Tract N: Male Reproductive |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| F: Respiratory Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| F: Respiratory Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| F: Respiratory Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| F: Respiratory Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| F: Respiratory Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
S: Gas |
D: Nitric Oxide F: Other Gas |
| F: Respiratory Tract |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| J: Biliary and Pancreatic Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| J: Biliary and Pancreatic Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| J: Biliary and Pancreatic Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| J: Biliary and Pancreatic Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| J: Biliary and Pancreatic Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
S: Gas |
F: Other Gas |
| J: Biliary and Pancreatic Tract |
3: Percutaneous 7: Via Natural or Artificial Opening 8: Via Natural or Artificial Opening Endoscopic |
U: Pancreatic Islet Cells |
0: Autologous 1: Nonautologous |
| J: Biliary and Pancreatic Tract |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| L: Pleural Cavity |
0: Open |
5: Adhesion Barrier |
Z: No Qualifier |
| L: Pleural Cavity |
3: Percutaneous |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| L: Pleural Cavity |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| L: Pleural Cavity |
3: Percutaneous |
3: Anti-inflammatory 5: Adhesion Barrier 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| L: Pleural Cavity |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| L: Pleural Cavity |
3: Percutaneous |
S: Gas |
F: Other Gas |
| L: Pleural Cavity |
4: Percutaneous Endoscopic |
5: Adhesion Barrier |
Z: No Qualifier |
| L: Pleural Cavity |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| L: Pleural Cavity |
7: Via Natural or Artificial Opening |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| L: Pleural Cavity |
7: Via Natural or Artificial Opening |
S: Gas |
F: Other Gas |
| M: Peritoneal Cavity |
0: Open |
5: Adhesion Barrier |
Z: No Qualifier |
| M: Peritoneal Cavity |
3: Percutaneous |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody Y: Hyperthermic |
| M: Peritoneal Cavity |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| M: Peritoneal Cavity |
3: Percutaneous |
3: Anti-inflammatory 5: Adhesion Barrier 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| M: Peritoneal Cavity |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| M: Peritoneal Cavity |
3: Percutaneous |
S: Gas |
F: Other Gas |
| M: Peritoneal Cavity |
4: Percutaneous Endoscopic |
5: Adhesion Barrier |
Z: No Qualifier |
| M: Peritoneal Cavity |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| M: Peritoneal Cavity |
7: Via Natural or Artificial Opening |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| M: Peritoneal Cavity |
7: Via Natural or Artificial Opening |
S: Gas |
F: Other Gas |
| P: Female Reproductive |
0: Open |
5: Adhesion Barrier |
Z: No Qualifier |
| P: Female Reproductive |
3: Percutaneous |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| P: Female Reproductive |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| P: Female Reproductive |
3: Percutaneous |
3: Anti-inflammatory 5: Adhesion Barrier 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance L: Sperm N: Analgesics, Hypnotics, Sedatives T: Destructive Agent V: Hormone |
Z: No Qualifier |
| P: Female Reproductive |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| P: Female Reproductive |
3: Percutaneous |
Q: Fertilized Ovum |
0: Autologous 1: Nonautologous |
| P: Female Reproductive |
3: Percutaneous |
S: Gas |
F: Other Gas |
| P: Female Reproductive |
4: Percutaneous Endoscopic |
5: Adhesion Barrier |
Z: No Qualifier |
| P: Female Reproductive |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| P: Female Reproductive |
7: Via Natural or Artificial Opening |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| P: Female Reproductive |
7: Via Natural or Artificial Opening |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| P: Female Reproductive |
7: Via Natural or Artificial Opening |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance L: Sperm N: Analgesics, Hypnotics, Sedatives T: Destructive Agent V: Hormone |
Z: No Qualifier |
| P: Female Reproductive |
7: Via Natural or Artificial Opening |
G: Other Therapeutic Substance |
C: Other Substance |
| P: Female Reproductive |
7: Via Natural or Artificial Opening |
Q: Fertilized Ovum |
0: Autologous 1: Nonautologous |
| P: Female Reproductive |
7: Via Natural or Artificial Opening |
S: Gas |
F: Other Gas |
| P: Female Reproductive |
8: Via Natural or Artificial Opening Endoscopic |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| P: Female Reproductive |
8: Via Natural or Artificial Opening Endoscopic |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| P: Female Reproductive |
8: Via Natural or Artificial Opening Endoscopic |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| P: Female Reproductive |
8: Via Natural or Artificial Opening Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| P: Female Reproductive |
8: Via Natural or Artificial Opening Endoscopic |
S: Gas |
F: Other Gas |
| Q: Cranial Cavity and Brain |
0: Open 3: Percutaneous |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| Q: Cranial Cavity and Brain |
0: Open 3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| Q: Cranial Cavity and Brain |
0: Open 3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance A: Stem Cells, Embryonic B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| Q: Cranial Cavity and Brain |
0: Open 3: Percutaneous |
E: Stem Cells, Somatic |
0: Autologous 1: Nonautologous |
| Q: Cranial Cavity and Brain |
0: Open 3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| Q: Cranial Cavity and Brain |
0: Open 3: Percutaneous |
S: Gas |
F: Other Gas |
| Q: Cranial Cavity and Brain |
7: Via Natural or Artificial Opening |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| Q: Cranial Cavity and Brain |
7: Via Natural or Artificial Opening |
S: Gas |
F: Other Gas |
| R: Spinal Canal |
0: Open |
A: Stem Cells, Embryonic |
Z: No Qualifier |
| R: Spinal Canal |
0: Open |
E: Stem Cells, Somatic |
0: Autologous 1: Nonautologous |
| R: Spinal Canal |
3: Percutaneous |
0: Antineoplastic |
2: High-dose Interleukin-2 3: Low-dose Interleukin-2 4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| R: Spinal Canal |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| R: Spinal Canal |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance A: Stem Cells, Embryonic B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| R: Spinal Canal |
3: Percutaneous |
E: Stem Cells, Somatic |
0: Autologous 1: Nonautologous |
| R: Spinal Canal |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| R: Spinal Canal |
3: Percutaneous |
S: Gas |
F: Other Gas |
| R: Spinal Canal |
7: Via Natural or Artificial Opening |
S: Gas |
F: Other Gas |
| S: Epidural Space |
3: Percutaneous |
0: Antineoplastic |
2: High-dose Interleukin-2 3: Low-dose Interleukin-2 4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| S: Epidural Space |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| S: Epidural Space |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| S: Epidural Space |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| S: Epidural Space |
3: Percutaneous |
S: Gas |
F: Other Gas |
| S: Epidural Space |
7: Via Natural or Artificial Opening |
S: Gas |
F: Other Gas |
| T: Peripheral Nerves and Plexi X: Cranial Nerves |
3: Percutaneous |
3: Anti-inflammatory B: Anesthetic Agent T: Destructive Agent |
Z: No Qualifier |
| T: Peripheral Nerves and Plexi X: Cranial Nerves |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| U: Joints |
0: Open |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| U: Joints |
0: Open |
G: Other Therapeutic Substance |
B: Recombinant Bone Morphogenetic Protein |
| U: Joints |
3: Percutaneous |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| U: Joints |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| U: Joints |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| U: Joints |
3: Percutaneous |
G: Other Therapeutic Substance |
B: Recombinant Bone Morphogenetic Protein C: Other Substance |
| U: Joints |
3: Percutaneous |
S: Gas |
F: Other Gas |
| U: Joints |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| V: Bones |
0: Open |
G: Other Therapeutic Substance |
B: Recombinant Bone Morphogenetic Protein C: Other Substance |
| V: Bones |
3: Percutaneous |
0: Antineoplastic |
5: Other Antineoplastic M: Monoclonal Antibody |
| V: Bones |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| V: Bones |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| V: Bones |
3: Percutaneous |
G: Other Therapeutic Substance |
B: Recombinant Bone Morphogenetic Protein C: Other Substance |
| V: Bones |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| W: Lymphatics |
3: Percutaneous |
0: Antineoplastic |
5: Other Antineoplastic M: Monoclonal Antibody |
| W: Lymphatics |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| W: Lymphatics |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| W: Lymphatics |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| Y: Pericardial Cavity |
3: Percutaneous |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| Y: Pericardial Cavity |
3: Percutaneous |
2: Anti-infective |
8: Oxazolidinones 9: Other Anti-infective |
| Y: Pericardial Cavity |
3: Percutaneous |
3: Anti-inflammatory 6: Nutritional Substance 7: Electrolytic and Water Balance Substance B: Anesthetic Agent H: Radioactive Substance K: Other Diagnostic Substance N: Analgesics, Hypnotics, Sedatives T: Destructive Agent |
Z: No Qualifier |
| Y: Pericardial Cavity |
3: Percutaneous |
G: Other Therapeutic Substance |
C: Other Substance |
| Y: Pericardial Cavity |
3: Percutaneous |
S: Gas |
F: Other Gas |
| Y: Pericardial Cavity |
4: Percutaneous Endoscopic |
G: Other Therapeutic Substance |
C: Other Substance |
| Y: Pericardial Cavity |
7: Via Natural or Artificial Opening |
0: Antineoplastic |
4: Liquid Brachytherapy Radioisotope 5: Other Antineoplastic M: Monoclonal Antibody |
| Y: Pericardial Cavity |
7: Via Natural or Artificial Opening |
S: Gas |
F: Other Gas |
Back to ICD-10 PCS (Procedure) Home